172 related articles for article (PubMed ID: 8592946)
21. Effect of phosphate supplementation on the expression of the mutant phenotype in murine X-linked hypophosphatemic rickets.
Tenenhouse HS; Martel J; Rubin J; Harvey N
Bone; 1994; 15(6):677-83. PubMed ID: 7873297
[TBL] [Abstract][Full Text] [Related]
22. Insulin-like growth factor binding protein (IGFBP)-3-bound IGF-I and IGFBP-3-bound IGF-II in growth hormone deficiency.
Belgorosky A; Rivarola MA
Horm Res; 1999; 52(2):60-5. PubMed ID: 10681634
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis.
Boonen S; Mohan S; Dequeker J; Aerssens J; Vanderschueren D; Verbeke G; Broos P; Bouillon R; Baylink DJ
J Bone Miner Res; 1999 Dec; 14(12):2150-8. PubMed ID: 10620075
[TBL] [Abstract][Full Text] [Related]
24. The insulin-like growth factor axis and growth in children with chronic renal failure: a report of the Southwest Pediatric Nephrology Study Group.
Powell DR; Durham SK; Liu F; Baker BK; Lee PD; Watkins SL; Campbell PG; Brewer ED; Hintz RL; Hogg RJ
J Clin Endocrinol Metab; 1998 May; 83(5):1654-61. PubMed ID: 9589673
[TBL] [Abstract][Full Text] [Related]
25. Abnormal parathyroid hormone stimulation of 25-hydroxyvitamin D-1 alpha-hydroxylase activity in the hypophosphatemic mouse. Evidence for a generalized defect of vitamin D metabolism.
Nesbitt T; Drezner MK; Lobaugh B
J Clin Invest; 1986 Jan; 77(1):181-7. PubMed ID: 3753708
[TBL] [Abstract][Full Text] [Related]
26. Plasma 24,25-dihydroxyvitamin D3 concentrations in X-linked hypophosphatemic mice: studies using mass fragmentographic and radioreceptor assays.
Cunningham J; Coldwell RD; Jones G; Tenenhouse HS; Trafford DJ; Makin HL
J Bone Miner Res; 1990 Feb; 5(2):173-7. PubMed ID: 2316405
[TBL] [Abstract][Full Text] [Related]
27. Parabiosis suggests a humoral factor is involved in X-linked hypophosphatemia in mice.
Meyer RA; Meyer MH; Gray RW
J Bone Miner Res; 1989 Aug; 4(4):493-500. PubMed ID: 2816498
[TBL] [Abstract][Full Text] [Related]
28. Serum insulin-like growth factor (IGF)-I and IGF-binding proteins in lung cancer patients.
Lee DY; Kim SJ; Lee YC
J Korean Med Sci; 1999 Aug; 14(4):401-4. PubMed ID: 10485619
[TBL] [Abstract][Full Text] [Related]
29. Acute effect of brief low- and high-intensity exercise on circulating insulin-like growth factor (IGF) I, II, and IGF-binding protein-3 and its proteolysis in young healthy men.
Schwarz AJ; Brasel JA; Hintz RL; Mohan S; Cooper DM
J Clin Endocrinol Metab; 1996 Oct; 81(10):3492-7. PubMed ID: 8855791
[TBL] [Abstract][Full Text] [Related]
30. Effect of the Hyp mutation and diet-induced hyperparathyroidism on renal parathyroid hormone- and forskolin-stimulated adenosine 3',5'-monophosphate production and brush border membrane phosphate transport.
Tenenhouse HS; Veksler A
Endocrinology; 1986 Mar; 118(3):1047-53. PubMed ID: 3004890
[TBL] [Abstract][Full Text] [Related]
31. Development and validation of a radioimmunoassay for mouse osteocalcin: paradoxical response in the Hyp mouse.
Gundberg CM; Clough ME; Carpenter TO
Endocrinology; 1992 Apr; 130(4):1909-15. PubMed ID: 1547718
[TBL] [Abstract][Full Text] [Related]
32. Defective bone formation by Hyp mouse bone cells transplanted into normal mice: evidence in favor of an intrinsic osteoblast defect.
Ecarot B; Glorieux FH; Desbarats M; Travers R; Labelle L
J Bone Miner Res; 1992 Feb; 7(2):215-20. PubMed ID: 1315116
[TBL] [Abstract][Full Text] [Related]
33. Genetic screening for X-linked hypophosphatemic mice and ontogenic characterization of the defect in the renal sodium-phosphate transporter.
Muller YL; Collins JF; Ghishan FK
Pediatr Res; 1998 Nov; 44(5):633-8. PubMed ID: 9803442
[TBL] [Abstract][Full Text] [Related]
34. A cross-sectional analysis of the association between diet and insulin-like growth factor (IGF)-I, IGF-II, IGF-binding protein (IGFBP)-2, and IGFBP-3 in men in the United Kingdom.
Young NJ; Metcalfe C; Gunnell D; Rowlands MA; Lane JA; Gilbert R; Avery KN; Davis M; Neal DE; Hamdy FC; Donovan J; Martin RM; Holly JM
Cancer Causes Control; 2012 Jun; 23(6):907-17. PubMed ID: 22527168
[TBL] [Abstract][Full Text] [Related]
35. Phosphate transport in immortalized cell cultures from the renal proximal tubule of normal and Hyp mice: evidence that the HYP gene locus product is an extrarenal factor.
Nesbitt T; Econs MJ; Byun JK; Martel J; Tenenhouse HS; Drezner MK
J Bone Miner Res; 1995 Sep; 10(9):1327-33. PubMed ID: 7502704
[TBL] [Abstract][Full Text] [Related]
36. Increased plasma 1,25-dihydroxyvitamin D after low calcium challenge in X-linked hypophosphatemic mice.
Meyer RA; Gray RW; Roos BA; Kiebzak GM
Endocrinology; 1982 Jul; 111(1):174-7. PubMed ID: 6896304
[TBL] [Abstract][Full Text] [Related]
37. Insulin-like growth factor binding-protein-3 (IGFBP-3).
Ranke MB
Best Pract Res Clin Endocrinol Metab; 2015 Oct; 29(5):701-11. PubMed ID: 26522455
[TBL] [Abstract][Full Text] [Related]
38. In vivo Response of X-linked hypophosphatemic mice to calcitonin.
Kiebzak GM; Meyer RA
Horm Metab Res; 1982 Apr; 14(4):216-20. PubMed ID: 6282728
[TBL] [Abstract][Full Text] [Related]
39. Relationships of serum levels of insulinlike growth factors with indices of bone metabolism and nutritional conditions in hemodialysis patients.
Nanba K; Nagake Y; Miyatake N; Nakao K; Akagi S; Sugimoto T; Yamasaki H; Oishi K; Ichikawa H; Makino H
Nephron; 2001 Oct; 89(2):145-52. PubMed ID: 11549896
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of gly56/gly80/gly81-mutant insulin-like growth factor-binding protein-3 in transgenic mice.
Silha JV; Gui Y; Mishra S; Leckstrom A; Cohen P; Murphy LJ
Endocrinology; 2005 Mar; 146(3):1523-31. PubMed ID: 15550509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
